Oxford Nanopore Technologies extends partnership with UPS Healthcare
Oxford Nanopore Technologies plc, which develops molecular sensing technology based on nanopores, has announced an extension of its collaboration with UPS Healthcare.
The collaboration will speed up the delivery of DNA/RNA sequencing products and consumables in the Asia Pacific region. Through UPS' specialised healthcare logistics solutions, Oxford Nanopore's customers will enjoy faster delivery and more time to focus on high-impact genomics research.
The flow cells will be stored in temperature-controlled facilities in Singapore and delivered within 24-48 hours via cold chain distribution capabilities, with the aiming being same-day despatch and faster delivery of flow cells.
Read more - Oxford Nanopore reports revenues of around £199m
This is Oxford Nanopore’s second region served by UPS Healthcare, with plans to expand the partnership to Australia and other regions globally expected by 2023.
Gordon Sanghera, CEO, Oxford Nanopore Technologies, commented: “We are proud to announce our expanded partnership with UPS Healthcare, which we expect to create an improved experience for our growing customer base throughout Asia Pacific.
“UPS’s mature infrastructure and reach globally has already improved our capacity in the US and will now allow us to increase our reach across the region without sacrificing speed or service.
“Through this collaboration, we are hopeful that our customers will be able to receive orders more quickly and with reduced complexity, leaving more time for the ground-breaking research critical to advancing improvements in human health, food and environments.”
Ianne Loh, senior director for UPS Healthcare in Asia Pacific, Middle East and Africa, said: “We’re excited to build on our trusted partnership with Oxford Nanopore Technologies to deliver its next-generation DNA sequencing technology to their customers in Asia Pacific, as the demand for such innovations open up possibilities for new applications and scientific research that can have a positive impact to the world.”
Read more - Oxford Nanopore sells £42.5m share in headquarters